Therefore, we believe that a more rigorous analysis on the role Tpl2 in human metabolic syndrome should be carried out before embarking on targeting Tpl2 for improvement of the metabolic state in obesity. This evidence concerns the gene MAP3K8 and obesity due to melanocortin 4 receptor deficiency.